Rujukan Monoamina oksidase

  1. ↑ "Monoamine oxidases: certainties and uncertainties". Current Medicinal Chemistry. 11 (15): 1965–82. August 2004. doi:10.2174/0929867043364810. PMID 15279561.
  2. ↑ "Structure and mechanism of monoamine oxidase". Current Medicinal Chemistry. 11 (15): 1983–93. August 2004. doi:10.2174/0929867043364784. PMID 15279562.
  3. ↑ "Tyramine oxidase: A new enzyme system in liver". The Biochemical Journal. 22 (4): 968–79. 1928. doi:10.1042/bj0220968. PMC 1252213. PMID 16744124.
  4. ↑ "Mary Bernheim and the discovery of monoamine oxidase". Brain Research Bulletin. 50 (5–6): 373. 1999. doi:10.1016/S0361-9230(99)00110-0. PMID 10643441.
  5. ↑ "Monoamine Oxidases (MAOs) as Privileged Molecular Targets in Neuroscience: Research Literature Analysis". Frontiers in Molecular Neuroscience. 12: 143. 2019. doi:10.3389/fnmol.2019.00143. PMC 6549493. PMID 31191248.
  6. ↑ "Regulation of MAO-A and MAO-B gene expression". Current Medicinal Chemistry. 11 (15): 1995–2005. August 2004. doi:10.2174/0929867043364757. PMID 15279563.
  7. ↑ "Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies". Journal of Cerebral Blood Flow and Metabolism. 33 (6): 863–71. June 2013. doi:10.1038/jcbfm.2013.19. PMC 3677103. PMID 23403377. Unknown parameter |displayauthors= ignored (bantuan)
  8. 1 2 "Monoamine oxidase activity in several structures of rat brain". Neurochemical Journal. 1 (3): 204–207. 2007-09-01. doi:10.1134/S1819712407030051.
  9. 1 2 3 4 "Monoamine oxidase activity in the rat pineal gland: Comparison with brain areas and alteration during aging". Advances in Gerontology. 6 (2): 111–116. 2016-04-01. doi:10.1134/S2079057016020120.
  10. ↑ Figure 11-4 in: Flower R, Rang HP, Dale MM, Ritter JM (2007). Rang & Dale's pharmacology. Edinburgh: Churchill Livingstone. ISBN 978-0-443-06911-6.
  11. ↑ "How are Biogenic Amines Metabolized by Monoamine Oxidases?". European Journal of Organic Chemistry. 2012 (36): 7057–7065. 2012-10-25. doi:10.1002/ejoc.201201122.
  12. ↑ "Structures and Mechanism of the Monoamine Oxidase Family". Biomolecular Concepts. 2 (5): 365–377. October 2011. doi:10.1515/BMC.2011.030. PMC 3197729. PMID 22022344.
  13. ↑ "Interactions of nitrogen-containing xenobiotics with monoamine oxidase (MAO) isozymes A and B: SAR studies on MAO substrates and inhibitors". Chemical Research in Toxicology. 14 (9): 1139–62. September 2001. doi:10.1021/tx010073b. PMID 11559028.
  14. ↑ "Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis". Exp Mol Med. 53 (7): 1148–1158. July 2021. doi:10.1038/s12276-021-00646-3. PMC 8333267 Check |pmc= value (bantuan). PMID 34244591.
  15. ↑ "Decreased blood platelet MAO activity in unmedicated chronic schizophrenic patients". The American Journal of Psychiatry. 133 (3): 323–6. March 1976. doi:10.1176/ajp.133.3.323. PMID 943955.
  16. ↑ "Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients". The American Journal of Psychiatry. 133 (4): 438–40. April 1976. doi:10.1176/ajp.133.4.438. PMID 1267046.
  17. ↑ "Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression". Archives of General Psychiatry. 63 (11): 1209–16. November 2006. doi:10.1001/archpsyc.63.11.1209. PMID 17088501. Unknown parameter |displayauthors= ignored (bantuan)
  18. ↑ "Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children". American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 134B (1): 110–4. April 2005. doi:10.1002/ajmg.b.30158. PMID 15717295. Unknown parameter |displayauthors= ignored (bantuan)
  19. ↑ "Platelet monoamine oxidase, personality and alcoholism: the rise, fall and resurrection". Neurotoxicology. 25 (1–2): 79–89. January 2004. doi:10.1016/S0161-813X(03)00115-3. PMID 14697883.
  20. ↑ "Monoamine oxidase activities in patients with migraine or with cluster headache during the acute phases and after treatment with L-5-hydroxytryptophan". Rivista di Patologia Nervosa e Mentale. 100 (5): 269–74. 1 October 2016. PMID 318025.
  21. ↑ "Monoamine oxidases A and B gene polymorphisms in migraine patients". Journal of the Neurological Sciences. 228 (2): 149–53. February 2005. doi:10.1016/j.jns.2004.11.045. PMID 15694196.
  22. ↑ "Clinical applications of MAO-inhibitors". Current Medicinal Chemistry. 11 (15): 2033–43. August 2004. doi:10.2174/0929867043364775. PMID 15279566.
  23. ↑ "The clinical characterization of the adult patient with depression aimed at personalization of management". World Psychiatry. 19 (3): 269–293. October 2020. doi:10.1002/wps.20771. PMC 7491646. PMID 32931110.
  24. ↑ "The role of monoamine oxidase inhibitors in current psychiatric practice". Journal of Psychiatric Practice. 10 (4): 239–48. July 2004. doi:10.1097/00131746-200407000-00005. PMC 2075358. PMID 15552546.
  25. ↑ "Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain". Psychopharmacology. 72 (1): 27–33. 1980. doi:10.1007/bf00433804. PMID 6781004.
  26. ↑ "Monoamine oxidase A and A/B knockout mice display autistic-like features". The International Journal of Neuropsychopharmacology. 16 (4): 869–88. May 2013. doi:10.1017/S1461145712000715. PMC 3517692. PMID 22850464. Unknown parameter |displayauthors= ignored (bantuan)
  27. ↑ "Cloning, after cloning, knock-out mice, and physiological functions of MAO A and B". Neurotoxicology. 25 (1–2): 21–30. January 2004. doi:10.1016/s0161-813x(03)00112-8. PMID 14697877.
  28. ↑ "Role of genotype in the cycle of violence in maltreated children". Science. 297 (5582): 851–4. August 2002. Bibcode:2002Sci...297..851C. doi:10.1126/science.1072290. PMID 12161658. Unknown parameter |displayauthors= ignored (bantuan)
  29. ↑ Sesardic N (2005). Making sense of heritability. Cambridge, UK: Cambridge University Press. ISBN 978-0-521-82818-5.
  30. ↑ "Monoamine oxidase A gene promoter polymorphism affects novelty seeking and reward dependence in healthy study participants". Psychiatric Genetics. 16 (2): 55–8. April 2006. doi:10.1097/01.ypg.0000199447.62044.ef. PMID 16538181.
  31. ↑ "A functional polymorphism in the monoamine oxidase A gene promoter". Human Genetics. 103 (3): 273–9. September 1998. doi:10.1007/s004390050816. PMID 9799080.
  32. ↑ "Monoamine oxidase expression during development and aging". Neurotoxicology. 25 (1–2): 155–65. January 2004. doi:10.1016/S0161-813X(03)00095-0. PMID 14697890.
  33. ↑ "[Pineal gland and brain structures monoamine oxidase activity in rats of different age]". Advances in Gerontology = Uspekhi Gerontologii (dalam bahasa Russian). 21 (3): 402–5. 2008. PMID 19432173.CS1 maint: unrecognized language (link)

Berkaitan